Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeMY
Item Type Journal Article
Title Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized Trial
Creator Barbieri et al.
Author Antoine Barbieri
Author Amélie Anota
Author Thierry Conroy
Author Sophie Gourgou-Bourgade
Author Beata Juzyna
Author Franck Bonnetain
Author Christian Lavergne
Author Caroline Bascoul-Mollevi
Abstract INTRODUCTION: A new longitudinal statistical approach was compared to the classical methods currently used to analyze health-related quality-of-life (HRQoL) data. The comparison was made using data in patients with metastatic pancreatic cancer. METHODS: Three hundred forty-two patients from the PRODIGE4/ACCORD 11 study were randomly assigned to FOLFIRINOX versus gemcitabine regimens. HRQoL was evaluated using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30. The classical analysis uses a linear mixed model (LMM), considering an HRQoL score as a good representation of the true value of the HRQoL, following EORTC recommendations. In contrast, built on the item response theory (IRT), our approach considered HRQoL as a latent variable directly estimated from the raw data. For polytomous items, we extended the partial credit model to a longitudinal analysis (longitudinal partial credit model [LPCM]), thereby modeling the latent trait as a function of time and other covariates. RESULTS: Both models gave the same conclusions on 11 of 15 HRQoL dimensions. HRQoL evolution was similar between the 2 treatment arms, except for the symptoms of pain. Indeed, regarding the LPCM, pain perception was significantly less important in the FOLFIRINOX arm than in the gemcitabine arm. For most of the scales, HRQoL changes over time, and no difference was found between treatments in terms of HRQoL. DISCUSSION: The use of LMM to study the HRQoL score does not seem appropriate. It is an easy-to-use model, but the basic statistical assumptions do not check. Our IRT model may be more complex but shows the same qualities and gives similar results. It has the additional advantage of being more precise and suitable because of its direct use of raw data.
Publication Medical Decision Making: An International Journal of the Society for Medical Decision Making
Volume 36
Issue 5
Pages 615-628
Date 07 2016
Journal Abbr Med Decis Making
Language eng
DOI 10.1177/0272989X15621883
ISSN 1552-681X
Library Catalog PubMed
Extra PMID: 26683246
Tags Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, EORTC QLQ-C30, Female, generalized linear mixed model, health-related quality of life, Humans, item response theory, longitudinal analysis, Longitudinal Studies, Male, Middle Aged, Neoplasm Metastasis, original, Pancreatic Neoplasms, Quality of Life
Date Added 2018/11/13 - 17:25:46
Date Modified 2019/05/21 - 14:46:40


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés